Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H37ClN8O4 |
InChIKeyTXDIRJCYNAWBOS-UHFFFAOYSA-N |
CAS Registry1472795-20-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | KR | 01 Nov 2013 |